The adoption of
single-use systems in biopharmaceutical production originated with the desire
to minimize cleaning and associated validation. Before long, bioprocessors
recognized the value of flexibility, reduced capital costs, and faster campaign
turnaround times attainable through disposable bioprocess equipment. Single-use
technologies have evolved from a supporting role for upstream operations (e.g.,
media storage and cell harvest) to near-complete platform processes that
include all downstream processing steps except chromatography.
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources